Clinical characteristics of the pediatric heart transplant patients treated with thyTreg cells (thy1-01) or included in the control (non-treated) group
| ID . | Sex . | Diagnosis . | Age at Tx . | Weight at Tx . | Type of Tx . | Age at thymectomy . | thyTreg dose . | thyTreg infusion . |
|---|---|---|---|---|---|---|---|---|
| thy1-01 | F | DCM | 7 mo | 6.1 kg | ABO incompatible | 7 mo | 122 × 106 (20 × 106/kg) | Day +9 after Tx |
| Ctrl-1 | M | CHD | 14 mo | 8.0 kg | ABO compatible | 7 mo | - | - |
| Ctrl-2 | M | CHD | 2 mo | 4.0 kg | ABO compatible | 5 days | - | - |
| Ctrl-3 | F | CHD | 5 mo | 5.0 kg | ABO incompatible | 4 days | - | - |
| Ctrl-4 | M | DCM | 4 mo | 6.5 kg | ABO compatible | 4 mo | - | - |
| ID . | Sex . | Diagnosis . | Age at Tx . | Weight at Tx . | Type of Tx . | Age at thymectomy . | thyTreg dose . | thyTreg infusion . |
|---|---|---|---|---|---|---|---|---|
| thy1-01 | F | DCM | 7 mo | 6.1 kg | ABO incompatible | 7 mo | 122 × 106 (20 × 106/kg) | Day +9 after Tx |
| Ctrl-1 | M | CHD | 14 mo | 8.0 kg | ABO compatible | 7 mo | - | - |
| Ctrl-2 | M | CHD | 2 mo | 4.0 kg | ABO compatible | 5 days | - | - |
| Ctrl-3 | F | CHD | 5 mo | 5.0 kg | ABO incompatible | 4 days | - | - |
| Ctrl-4 | M | DCM | 4 mo | 6.5 kg | ABO compatible | 4 mo | - | - |
F, female; M, male; DCM, dilated cardiomyopathy; CHD, congenital heart disease; Tx, transplant.